According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is 0,59ย โฌ. In 2021 the company made an earnings per share (EPS) of 0,03847ย โฌ an increase over its 2020 EPS that were of -7,61ย โฌ.